3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 25 0 0 0 0 0 0 0999 V2000
-0.9967 -0.1549 0.0004 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.0314 -1.0645 -0.0001 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5744 0.2103 0.0005 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3832 -0.0645 0.0004 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8846 0.8904 0.0001 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1286 0.3045 -0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0002 1.1865 0.0003 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1582 -1.2242 0.0001 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7397 -1.3085 0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1670 0.1181 -0.0008 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3921 1.2778 -0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5501 -1.1329 -0.0004 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4443 0.9618 -0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6070 1.9346 0.0003 H 0 0 0 0 0 0 0 0 0 0 0 0
0.4515 2.1222 0.0006 H 0 0 0 0 0 0 0 0 0 0 0 0
0.7367 -2.2236 0.0002 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.3259 -2.3071 0.0003 H 0 0 0 0 0 0 0 0 0 0 0 0
2.8618 2.2582 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
3.1439 -2.0435 -0.0004 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.0110 0.6809 0.8929 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.3496 2.0522 -0.0126 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.0208 0.6618 -0.8808 H 0 0 0 0 0 0 0 0 0 0 0 0
5.1368 -0.6302 -0.0030 H 0 0 0 0 0 0 0 0 0 0 0 0
5.0222 1.1170 -0.0030 H 0 0 0 0 0 0 0 0 0 0 0 0
1 4 1 0 0 0 0
1 5 1 0 0 0 0
1 9 1 0 0 0 0
2 6 1 0 0 0 0
2 9 2 0 0 0 0
3 10 1 0 0 0 0
3 23 1 0 0 0 0
3 24 1 0 0 0 0
4 7 2 0 0 0 0
4 8 1 0 0 0 0
5 6 2 0 0 0 0
5 14 1 0 0 0 0
6 13 1 0 0 0 0
7 11 1 0 0 0 0
7 15 1 0 0 0 0
8 12 2 0 0 0 0
8 16 1 0 0 0 0
9 17 1 0 0 0 0
10 11 2 0 0 0 0
10 12 1 0 0 0 0
11 18 1 0 0 0 0
12 19 1 0 0 0 0
13 20 1 0 0 0 0
13 21 1 0 0 0 0
13 22 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
4-(4-methylimidazol-1-yl)aniline
4.2 InChl
InChI=1S/C10H11N3/c1-8-6-13(7-12-8)10-4-2-9(11)3-5-10/h2-7H,11H2,1H3
4.3 InChlKey
PJUPTRYCQKQLCI-UHFFFAOYSA-N
4.4 Canonical SMILES
CC1=CN(C=N1)C2=CC=C(C=C2)N
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病